| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $155.1M | +62.1% |
| SG&A Expense | $55.2M | +28.7% |
| Operating Income | -$212.3M | +43.3% |
| Pre-tax Income | -$217.0M | +43.1% |
| Income Tax | -$747K | -755.3% |
| Net Income | -$216.2M | +43.3% |
| EPS (Basic) | -$2.31 | +54.4% |
| EPS (Diluted) | -$2.31 | +54.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $393.6M | -33.9% |
| Current Assets | $437.7M | -30.4% |
| Total Assets | $444.3M | -29.4% |
| Current Liabilities | $38.3M | +55.6% |
| Long-term Debt | $69.8M | -7.8% |
| Total Liabilities | $108.1M | -21.7% |
| Stockholders' Equity | $336.2M | -31.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$200.5M | -48.4% |
| Capital Expenditures | $1.1M | +511.3% |
| Investing Cash Flow | -$931K | -101.5% |
| Financing Cash Flow | $457K | -99.9% |
| Free Cash Flow | -$201.7M | -49.1% |